Women with bipolar disorder and regular cycles report severe premenstrual symptoms

A team of Norwegian researchers has documented something clinicians have largely overlooked: women with bipolar disorder who menstruate regularly experience notably worse premenstrual symptoms than those whose cycles are irregular. The finding emerged from a survey of 267 women of reproductive age with bipolar disorder, presented at the 2026 ECNP Congress in Munich, and it raises uncomfortable questions about how mental health care and reproductive health have remained siloed from each other.

The numbers tell a clear story. Among the women surveyed, 62 percent had regular menstrual cycles, and these women reported severe premenstrual symptoms—irritability, anger, relationship strain, physical discomfort, and significant disruption to work and daily life—occurring every month or nearly every month over the past year. The remaining 38 percent, whose cycles were irregular, reported these symptoms far less frequently. What made the finding unexpected, according to lead researcher Dr. Sofie Ragnhild Aminoff of Oslo University Hospital, was a secondary pattern: women with regular cycles were actually less likely to be using hormonal contraceptives than women with irregular cycles. Most of the sample—93 percent—had tried hormonal birth control at some point, but a larger proportion of the regular-cycle group had stopped taking it, citing side effects and expressing reluctance about hormone use altogether.

The implications cut deeper than the data alone suggests. Bipolar disorder affects roughly 1 to 2 percent of women globally, which translates to approximately 235,000 women of childbearing age in a large European country like the UK or France. A majority of these women experience some form of premenstrual disturbance—either worsening of their bipolar symptoms or distinct premenstrual symptoms—yet reproductive mental health in women with serious mental illness remains profoundly understudied. Dr. Aminoff has encountered women whose mood swings, psychotic symptoms, and even suicidal ideation track closely with their menstrual cycle. These are not minor fluctuations; they shape how women navigate work, relationships, and their own safety.

Yet the clinical response has been fragmented. Women with bipolar disorder frequently report that their premenstrual symptoms are dismissed or minimized, and few receive targeted treatment. There are no clear guidelines for psychiatrists on how to assess and manage premenstrual burden alongside mood-stabilizing medications. There are no established protocols for collaboration between mental health providers and gynecologists. The result is that women and their doctors make treatment decisions in the dark, without the information they need.

Dr. Aminoff's call is straightforward: premenstrual symptoms in women with bipolar disorder must be taken seriously. Assessment of premenstrual symptom burden, tailored decisions about hormonal contraception, and careful coordination of mood-stabilizing medication should be standard care. They are not. She also emphasizes that psychiatry and gynecology need to work together, and that future research must examine not only mental health symptoms but also hormonal contraception and reproductive health as interconnected pieces of the same puzzle.

The research community has begun to listen. Professor Louise Howard, an emerita professor in women's mental health at King's College London, welcomed the preliminary findings as addressing a gap that has persisted far too long. Dr. Clare Dolman, co-chair of the Bipolar Commission and ambassador for Bipolar UK, went further, noting that premenstrual sensitivity to hormonal change can signal vulnerability to relapse at other critical moments—pregnancy, childbirth, perimenopause—making this not just a quality-of-life issue but a safety concern.

It is important to note that these findings are preliminary. The research came from an online survey and has not yet undergone peer review. The authors themselves stress this limitation. But the gap they have identified—between what women experience and what the health system is equipped to address—is real and documented. The next phase requires rigorous, peer-reviewed research, clearer clinical guidelines, and a fundamental shift in how psychiatry and gynecology approach women's reproductive mental health.